Chrysos (C79) Mining Forum Americas 2026 summary
Event summary combining transcript, slides, and related documents.
Mining Forum Americas 2026 summary
28 Sep, 2026Technology adoption and industry impact
PhotonAssay technology is rapidly replacing traditional fire assay methods due to its speed, safety, and accuracy, with major gold miners and laboratories globally adopting it.
PhotonAssay delivers results in about two minutes versus up to a day for fire assay, enabling near real-time operational decisions.
The technology handles larger, more representative samples, is non-destructive, and eliminates hazardous chemicals and lead exposure, addressing significant ESG and OH&S concerns.
PhotonAssay offers zero Scope 1 CO₂ emissions, up to 90% lower energy use, and no contaminated waste compared to fire assay.
Accuracy is enhanced, with PhotonAssay results matching fire assay to within ±4%, but with less variability and error.
Business model and financial performance
Units are built and owned by the company, then leased to miners or labs on take-or-pay contracts, ensuring recurring revenue with no upfront capital required from customers.
Each unit costs AUD 4 million to build, generates AUD 2 million in annual revenue, and yields AUD 1.5 million gross profit per year, with a payback period of approximately 2.7 years.
Contracts are typically five years and renewable, with units expected to remain in use for the life of mine or indefinitely in labs.
FY financials show AUD 88.1 million revenue (up 33%), AUD 27.2 million EBITDA (up 68%), and AUD 17.9 million operating cash flow (up 103%), with utilization rising from 41% to 59%.
Take-or-pay contracts provide revenue stability, with 71% of FY26 revenue from minimum payments.
Market expansion and strategic positioning
46 units are deployed at 34 sites, 87 contracted, and 35 more to be deployed, with a two-year pipeline and significant growth potential.
Market share is less than 10% globally, but dominant in Australia; expansion into silver, copper, and other elements is underway, with alternative analysis volumes up 55% year-on-year.
All major global laboratories are channel partners, facilitating access to new regions and miners, and the platform is embedded with Tier-1 miners and all four major global geochemistry labs.
The addressable market is estimated at 610 sites (200 hub labs, 410 mine sites), with a long runway for growth.
The company is the sole provider of PhotonAssay, protected by extensive patents, proprietary IP, and a global service network.
Latest events from Chrysos
- Record revenue and EBITDA growth, with strong PhotonAssay adoption and robust FY27 outlook.C79
H2 2026 - Record sample volumes and new leases drive revenue and operational momentum.C79
Trading update - Record revenue and EBITDA growth driven by global PhotonAssay adoption and strong funding.C79
H1 2026 - 46% revenue and 80% EBITDA growth, global expansion, and strong FY26 outlook.C79
H2 2025 - Q1 FY25 revenue up 54% YoY to $13.7m, with record sample volumes and global expansion.C79
Q1 2025 - 69% revenue growth and 156% EBITDA increase driven by global PhotonAssay expansion.C79
H2 2024 - Q4 revenue up 58% YoY to $13.5m; FY25 guidance: $60–70m revenue, $9–19m EBITDA.C79
Q4 2024 - Revenue up 54% and EBITDA up 150% year-on-year, with strong global expansion and new contracts.C79
H1 2025 - Q2 FY25 revenue up 53% YoY to $15.3m, with record sample volumes and global expansion.C79
Q2 2025